466
Participants
Start Date
January 20, 2022
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2027
Intravenous tenecteplase
Intravenous tenecteplase (TNK). Patients will receive intravenous TNK (0.25mg/kg, maximum 25mg, administered as a bolus over 5 seconds).
Placebo
Placebo matching IV TNK
RECRUITING
Hospital Moinhos de Vento, Porto Alegre
RECRUITING
Hospital das Clínicas Botucatu, Botucatu
RECRUITING
Hospital das Clínicas - UNICAMP, Campinas
RECRUITING
Hospital Universitário Maria Aparecida Pedrossian, Campo Grande
RECRUITING
Hospital das Clínicas UFPR, Curitiba
RECRUITING
Clinica Neurologica e Neurocirurgica de Joinville, Joinville
RECRUITING
Hospital Metropolitano de Maceió, Maceió
RECRUITING
Hospital de Clínicas de Porto Alegre, Porto Alegre
RECRUITING
Hospital de Base São José do Rio Preto, São José do Rio Preto
RECRUITING
Santa Casa de Misericordia de Sao Paulo, São Paulo
RECRUITING
Hospital Estadual Central, Vitória
RECRUITING
Hospital Geral de Fortaleza, Fortaleza
RECRUITING
Hospital de Clínicas de Porto Alegre, Porto Alegre
RECRUITING
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto
RECRUITING
Hospital São Paulo, São Paulo
Collaborators (1)
Ministry of Health, Brazil
OTHER_GOV
Boehringer Ingelheim
INDUSTRY
Brainomix Limited
INDUSTRY
iSchemaView, Inc
UNKNOWN
Hospital Moinhos de Vento
OTHER